Evidence & regulatory context
- Mechanism
- Cell therapy (human activated macrophage suspension); not a ChEMBL entity; no matching trial identified
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
Guinea pigChemical/toxinHairless guinea pigMaleIntradermal injection into the wound bedSingle treatment at 15 min or 6 h after exposure; repeated treatment at 15 min,…
Model: Sulfur mustard vapour cutaneous chemical burn
A single early injection reduced damaged epidermal cells and vesication at 24 h, and repeated injections significantly reduced wound area and improved barrier function measured by trans-epidermal water loss up to 10 days, with prolonged inflammatory cell influx.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.